Wolverine Asset Management’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

Wolverine Asset Management’s Portfolio MNTA Stock Details MNTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-15,000	Closed	-$787K	–	2114
2020 Q3	$787K	Buy	+15,000	New	+$621K	0.01%	618
2014 Q4	–	Sell	-940	Closed	-$33K	–	2606
2014 Q3	$33K	Buy	940 +847	+911%	+$9.66K	﹤0.01%	1648
2014 Q2	$7K	Buy	93 +53	+133%	+$626	﹤0.01%	1957
2014 Q1	$1K	Buy	+40	New	+$677	﹤0.01%	2292

Wolverine Asset Management's MNTA Position: Q4 2020 in Review

Wolverine Asset Management sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q4 2020, closing a stake of 95,857 shares — an estimated $5.03M sold.

Wolverine Asset Management first reported a position in MNTA in Q1 2014 and held it in 3 quarters. The position peaked at $5.03M in Q3 2020. 0 funds tracked by Wall St. Rank hold MNTA as of Q4 2020.

Wolverine Asset Management reported no remaining Momenta Pharmaceuticals, Inc. position as of Q4 2020 after selling out during the quarter.
Wolverine Asset Management sold 95,857 Momenta Pharmaceuticals, Inc. shares in Q4 2020, an estimated $5.03M.
Wolverine Asset Management first reported a position in Momenta Pharmaceuticals, Inc. in Q1 2014 and held it in 3 quarters.
Wolverine Asset Management's Momenta Pharmaceuticals, Inc. position peaked at $5.03M in Q3 2020.
0 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q4 2020.

Based on Wolverine Asset Management's 13F filing for Q4 2020, filed 12 Feb 2021.